🇺🇸 FDA
Patent

US 10130618

Pharmaceutical combinations of dabigatran and proton pump inhibitors

granted A61KA61K31/4439A61K31/5377

Quick answer

US patent 10130618 (Pharmaceutical combinations of dabigatran and proton pump inhibitors) held by SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4439, A61K31/5377, A61K9/1635, A61K9/1652